InDex Pharmaceuticals brings forward the publication of the interim report for Q1 2024
22 April, 2024 – InDex Pharmaceuticals Holding AB (publ) (“InDex Pharmaceuticals”) announces that the company changes the date for when the interim report for Q1 2024 will be published. The interim report will now be published on Friday April 26, 2024 instead of Tuesday May 7, 2024 as previously communicated.The reason for bringing forward the publication of the interim report is to facilitate and speed up the process of determining if the reverse merger being evaluated is achievable. For more information:Jenny Sundqvist, CEOPhone: +46 8 122 038 50E-mail: jenny.sundqvist@